Timosaponin A-III reverses multi-drug resistance in human chronic myelogenous leukemia K562/ADM cells via downregulation of MDR1 and MRP1 expression by inhibiting PI3K/Akt signaling pathway. [electronic resource]
Producer: 20161226Description: 2063-70 p. digitalISSN:- 1791-2423
- ATP Binding Cassette Transporter, Subfamily B -- genetics
- Antineoplastic Agents -- pharmacology
- Cell Proliferation -- drug effects
- Cell Survival -- drug effects
- Down-Regulation
- Doxorubicin -- pharmacology
- Drug Resistance, Multiple -- drug effects
- Drug Resistance, Neoplasm -- drug effects
- Gene Expression Regulation, Neoplastic -- drug effects
- Humans
- K562 Cells
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- drug therapy
- Multidrug Resistance-Associated Proteins -- genetics
- Phosphatidylinositol 3-Kinases -- genetics
- Proto-Oncogene Proteins c-akt -- genetics
- Saponins -- pharmacology
- Signal Transduction -- drug effects
- Steroids -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.